National Breast and Cervical Cancer Early Detection Program

(a) National Breast and Cervical Cancer Early Detection Program Title XV of the Public Health Service Act (42 U.S.C. 300k et seq.) is amended— (1) in section 1501 (42 U.S.C. 300k)— (A) in subsection (a)— (i) in paragraph (2), by striking the provision of appropriate follow-up services and support services such as case management and inserting that appropriate follow-up services are provided; (ii) in paragraph (3), by striking programs for the detection and control and inserting programs for the prevention, detection, and control; (iii) in paragraph (4), by striking the detection and control and inserting the prevention, detection, and control; (iv) in paragraph (5)— (I) by striking monitor and inserting ensure; and (II) by striking; and and inserting a semicolon; (v) by redesignating paragraph (6) as paragraph (9); (vi) by inserting after paragraph (5) the following: (6) to enhance appropriate support activities to increase breast and cervical cancer screenings, such as navigation of health care services, implementation of evidence-based or evidence-informed strategies to increase breast and cervical cancer screening in health care settings, and facilitation of access to health care settings; (7) to reduce disparities in breast and cervical cancer incidence, morbidity, and mortality, including in populations with higher than average rates; (8) to improve access to breast and cervical cancer screening and diagnostic services and reduce related barriers, including factors that relate to negative health outcomes; and; and (vii) in paragraph (9), as so redesignated, by striking through (5) and inserting through (8); and (B) by striking subsection (d); (2) in section 1503 (42 U.S.C. 300m)— (A) in subsection (a)— (i) in paragraph (1), by striking that, initially and all that follows through the semicolon and inserting that appropriate breast and cervical cancer screening and diagnostic services are provided consistent with relevant evidence-based recommendations; and; (ii) by striking paragraphs (2) and (4); (iii) by redesignating paragraph (3) as paragraph (2); and (iv) in paragraph (2), as so redesignated, by striking; and and inserting a period; and (B) by striking subsection (d); (3) in section 1508(b) (42 U.S.C. 300n–4(b))— (A) by striking 1 year after the date of the enactment of the National Breast and Cervical Cancer Early Detection Program Reauthorization of 2007, and annually thereafter, and inserting 2 years after the date of enactment of the SCREENS for Cancer Act of 2025, and every 5 years thereafter,; (B) by striking Labor and Human Resources and inserting Health, Education, Labor, and Pensions; and (C) by striking preceding fiscal year and inserting preceding 2 fiscal years in the case of the first report after the date of enactment of the SCREENS for Cancer Act of 2025, and preceding 5 fiscal years for each report thereafter,; and (4) in section 1510(a) (42 U.S.C. 300n–5(a))— (A) by striking 2011, and and inserting 2011,; and (B) by inserting, and $235,500,000 for each of fiscal years 2026 through 2030 before the period at the end. (b) GAO study Not later than September 30, 2027, the Comptroller General of the United States shall report to the Committee on Health, Education, Labor, and Pensions of the Senate and the Committee on Energy and Commerce of the House of Representatives on the work of the National Breast and Cervical Cancer Early Detection Program, including— (1) an estimate of the number of individuals eligible for services provided under such program; (2) a summary of trends in the number of individuals served through such program; and (3) an assessment of any factors that may be driving the trends identified under paragraph (2), including any barriers to accessing breast and cervical cancer screenings provided by such program.

(a) National Breast and Cervical Cancer Early Detection Program Title XV of the Public Health Service Act (42 U.S.C. 300k et seq.) is amended— (1) in section 1501 (42 U.S.C. 300k)— (A) in subsection (a)— (i) in paragraph (2), by striking the provision of appropriate follow-up services and support services such as case management and inserting that appropriate follow-up services are provided; (ii) in paragraph (3), by striking programs for the detection and control and inserting programs for the prevention, detection, and control; (iii) in paragraph (4), by striking the detection and control and inserting the prevention, detection, and control; (iv) in paragraph (5)— (I) by striking monitor and inserting ensure; and (II) by striking; and and inserting a semicolon; (v) by redesignating paragraph (6) as paragraph (9); (vi) by inserting after paragraph (5) the following: (6) to enhance appropriate support activities to increase breast and cervical cancer screenings, such as navigation of health care services, implementation of evidence-based or evidence-informed strategies to increase breast and cervical cancer screening in health care settings, and facilitation of access to health care settings; (7) to reduce disparities in breast and cervical cancer incidence, morbidity, and mortality, including in populations with higher than average rates; (8) to improve access to breast and cervical cancer screening and diagnostic services and reduce related barriers, including factors that relate to negative health outcomes; and; and (vii) in paragraph (9), as so redesignated, by striking through (5) and inserting through (8); and (B) by striking subsection (d); (2) in section 1503 (42 U.S.C. 300m)— (A) in subsection (a)— (i) in paragraph (1), by striking that, initially and all that follows through the semicolon and inserting that appropriate breast and cervical cancer screening and diagnostic services are provided consistent with relevant evidence-based recommendations; and; (ii) by striking paragraphs (2) and (4); (iii) by redesignating paragraph (3) as paragraph (2); and (iv) in paragraph (2), as so redesignated, by striking; and and inserting a period; and (B) by striking subsection (d); (3) in section 1508(b) (42 U.S.C. 300n–4(b))— (A) by striking 1 year after the date of the enactment of the National Breast and Cervical Cancer Early Detection Program Reauthorization of 2007, and annually thereafter, and inserting 2 years after the date of enactment of the SCREENS for Cancer Act of 2025, and every 5 years thereafter,; (B) by striking Labor and Human Resources and inserting Health, Education, Labor, and Pensions; and (C) by striking preceding fiscal year and inserting preceding 2 fiscal years in the case of the first report after the date of enactment of the SCREENS for Cancer Act of 2025, and preceding 5 fiscal years for each report thereafter,; and (4) in section 1510(a) (42 U.S.C. 300n–5(a))— (A) by striking 2011, and and inserting 2011,; and (B) by inserting, and $235,500,000 for each of fiscal years 2026 through 2030 before the period at the end. (b) GAO study Not later than September 30, 2027, the Comptroller General of the United States shall report to the Committee on Health, Education, Labor, and Pensions of the Senate and the Committee on Energy and Commerce of the House of Representatives on the work of the National Breast and Cervical Cancer Early Detection Program, including— (1) an estimate of the number of individuals eligible for services provided under such program; (2) a summary of trends in the number of individuals served through such program; and (3) an assessment of any factors that may be driving the trends identified under paragraph (2), including any barriers to accessing breast and cervical cancer screenings provided by such program.